25 results on '"Nadal, E."'
Search Results
2. Thromboelastographic evaluation of hemostatic balance in cirrhotic patients with infection
3. HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience
4. OC.03.9 SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS NOT ASSOCIATED WITH HIGHER MORTALITY IF COMPARED WITH OTHER INFECTIONS IN PATIENTS AWAITING LIVER TRANSPLANTATION (LT)
5. Peripheral NK cells in patients with HCV recurrence after liver transplantation during interferon-free antiviral therapy
6. Circulating microparticles and risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma
7. OC.03.7 CIRCULATING MICROPARTICLES AND RISK OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
8. P.10.8 PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
9. Presentation and outcome in patients with drug induced liver injury: A three-year experience
10. PC.01.1 MANAGEMENT OF BILIARY ANASTOMOTIC STRICTURE AFTER LIVER TRANSPLANTATION (BASALT STUDY): RESULTS OF A NATIONAL SURVEY IN ITALY
11. Transition of pediatric liver transplanted recipients to Adult Healthcare Service: A single center cohort
12. PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
13. Effects of non-selective β-blockers on hemodynamics and paracentesis induced circulatory dysfunction in patients with cirrhosis undergoing large volume paracentesis
14. P.16.10 EFFECTS OF NON SELECTIVE β-BLOCKERS (NSBB) ON HEMODYNAMICS AND PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION IN CIRRHOTIC PATIENTS UNDERGOING LARGE VOLUME PARACENTESIS (LVP)
15. OC.19.2 BLEEDING-UNRELATED MORTALITY IS NOT INCREASED IN PATIENTS WITH CIRRHOSIS AND ASCITES ON TREATMENT WITH β-BLOCKERS: A META-ANALYSIS
16. Bleeding-unrelated mortality is not increased in patients with cirrhosis and ascites on treatment with β-blockers: A meta-analysis
17. Effect of portal vein thrombosis (PVT) on survival after liver transplantation (LT): A meta-analysis
18. F-48 Liver transplantation for HBV-related liver disease: the experience of Padua Liver Transplant Center
19. F-33 Predictors of response to anticoagulant therapy for the treatment of portal vein thrombosis (PVT) in cirrhosis patients
20. O7 FUNCTIONAL STUDY OF INTESTINAL BARRIER IN PATIENTS WITH LIVER CIRRHOSIS AND PORTAL HYPERTENSION
21. F-25 Prospective validation of noninvasive methods to assess liver fibrosis in HCV patients after liver transplantation (LT)
22. P.1.128: FUNCTIONAL STUDY OF THE INTESTINAL BARRIER IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION
23. OC-33 Evaluation of intestinal barrier function and histologic aspects “in vivo” and its normalization after β-blocker treatment in patients with cirrhosis and portal hypertension
24. P.144 ALGORYTHM FOR THE TREATMENT OF PORTAL (PVT) AND SPLANCNINC VEINS THROMBOSIS (SVT) IN PATIENTS WITH LIVER CIRRHOSIS
25. Effects of Non-Selective β-Blockers on hemodynamic and Paracentesis Induced Circulatory Dysfunction in cirrhotics undergoing large volume paracentesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.